Patrik Jeanmonod Biography and Net Worth



Patrik Jeanmonod is the CFO of Cytek Biosciences. They are 58 years old.

What is Patrik Jeanmonod's net worth?

The estimated net worth of Patrik Jeanmonod is at least $485.68 thousand as of December 26th, 2023. Jeanmonod owns 93,400 shares of Cytek Biosciences stock worth more than $485,680 as of December 5th. This net worth estimate does not reflect any other assets that Jeanmonod may own. Additionally, Jeanmonod receives a salary of $412,540.00 as CFO at Cytek Biosciences. Learn More about Patrik Jeanmonod's net worth.

How old is Patrik Jeanmonod?

Jeanmonod is currently 57 years old. There are 6 older executives and no younger executives at Cytek Biosciences. The oldest executive at Cytek Biosciences is Mr. William D. McCombe, Chief Financial Officer, who is 66 years old. Learn More on Patrik Jeanmonod's age.

What is Patrik Jeanmonod's salary?

As the CFO of Cytek Biosciences, Inc., Jeanmonod earns $412,540.00 per year. There are 3 executives that earn more than Jeanmonod. The highest earning executive at Cytek Biosciences is Dr. Wenbin Jiang Ph.D., President, CEO & Chairman of the Board, who commands a salary of $964,210.00 per year. Learn More on Patrik Jeanmonod's salary.

How do I contact Patrik Jeanmonod?

The corporate mailing address for Jeanmonod and other Cytek Biosciences executives is , , . Cytek Biosciences can also be reached via phone at 877-922-9835 and via email at [email protected]. Learn More on Patrik Jeanmonod's contact information.

Has Patrik Jeanmonod been buying or selling shares of Cytek Biosciences?

Patrik Jeanmonod has not been actively trading shares of Cytek Biosciences during the last quarter. Most recently, Patrik Jeanmonod sold 3,000 shares of the business's stock in a transaction on Tuesday, December 26th. The shares were sold at an average price of $9.50, for a transaction totalling $28,500.00. Following the completion of the sale, the chief financial officer now directly owns 93,400 shares of the company's stock, valued at $887,300. Learn More on Patrik Jeanmonod's trading history.

Who are Cytek Biosciences' active insiders?

Cytek Biosciences' insider roster includes Patrik Jeanmonod (CFO), Wenbin Jiang (CEO), William Mccombe (CFO), and Ming Yan (CTO). Learn More on Cytek Biosciences' active insiders.

Are insiders buying or selling shares of Cytek Biosciences?

During the last year, Cytek Biosciences insiders bought shares 2 times. They purchased a total of 70,000 shares worth more than $194,600.00. The most recent insider tranaction occured on June, 2nd when CFO William D Mccombe bought 35,000 shares worth more than $97,300.00. Insiders at Cytek Biosciences own 10.3% of the company. Learn More about insider trades at Cytek Biosciences.

Information on this page was last updated on 6/2/2025.

Patrik Jeanmonod Insider Trading History at Cytek Biosciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/26/2023Sell3,000$9.50$28,500.0093,400View SEC Filing Icon  
11/24/2023Sell3,000$6.94$20,820.0096,400View SEC Filing Icon  
10/24/2023Sell3,000$4.68$14,040.0096,084View SEC Filing Icon  
9/25/2023Sell3,000$6.38$19,140.0099,084View SEC Filing Icon  
8/24/2023Sell3,000$7.69$23,070.00102,084View SEC Filing Icon  
6/26/2023Sell3,000$7.96$23,880.00104,768View SEC Filing Icon  
5/24/2023Sell3,000$7.76$23,280.00107,768View SEC Filing Icon  
4/24/2023Sell3,000$10.24$30,720.00108,201View SEC Filing Icon  
3/24/2023Sell3,000$8.33$24,990.00111,201View SEC Filing Icon  
1/24/2023Sell3,500$11.05$38,675.0076,132View SEC Filing Icon  
12/27/2022Sell3,500$9.77$34,195.0079,632View SEC Filing Icon  
11/25/2022Sell3,500$14.30$50,050.0083,132View SEC Filing Icon  
10/24/2022Sell3,500$15.16$53,060.0085,563View SEC Filing Icon  
9/26/2022Sell3,500$12.63$44,205.0089,063View SEC Filing Icon  
8/24/2022Sell3,500$13.45$47,075.0092,563View SEC Filing Icon  
8/1/2022Sell3,500$12.80$44,800.0094,994View SEC Filing Icon  
See Full Table

Patrik Jeanmonod Buying and Selling Activity at Cytek Biosciences

This chart shows Patrik Jeanmonod's buying and selling at Cytek Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cytek Biosciences Company Overview

Cytek Biosciences logo
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Read More

Today's Range

Now: $5.20
Low: $4.96
High: $5.37

50 Day Range

MA: $4.49
Low: $3.38
High: $5.88

2 Week Range

Now: $5.20
Low: $2.37
High: $7.30

Volume

1,073,370 shs

Average Volume

1,828,866 shs

Market Capitalization

$664.87 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.29